Your browser doesn't support javascript.
SARS-CoV-2 variants and vaccination.
Liu, Yang; Liu, Jianying; Shi, Pei-Yong.
  • Liu Y; Institute of Infectious Disease, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
  • Liu J; Institute of Infectious Disease, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
  • Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston TX, USA.
Zoonoses (Burlingt) ; 2(1)2022.
Article in English | MEDLINE | ID: covidwho-2025750
ABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused global destruction since its emergence in late 2019. Over the past two years, the virus has continuously evolved in human host, leading to emergence of variants with changed viral transmission, disease severity, and evasion of immunity. Although vaccines have been developed for the coronavirus disease 2019 (COVID-19) at an unprecedently pace, the variants have constantly posed threats to the effectiveness of the approved vaccines. In this short communication, we review the key variants and discuss their implications in viral replication, transmission, and immune evasion.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Year: 2022 Document Type: Article Affiliation country: ZOONOSES-2022-0001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Topics: Vaccines / Variants Language: English Year: 2022 Document Type: Article Affiliation country: ZOONOSES-2022-0001